PACIRA BIOSCIENCES INC (PCRX) Stock Balance Sheet
NASDAQ:PCRX - US6951271005 - Common Stock
27.18 USD
-0.04 (-0.15%)
27.18 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 300.48M | 276.77M | 153.30M | 104.10M | 585.60M | |||
| Marketable Securities | 145.38M | 207.84M | 125.28M | 184.50M | 70.80M | |||
| Receivables | 114.37M | 113.30M | 105.56M | 98.40M | 96.30M | |||
| Inventories | 148.16M | 125.28M | 104.35M | 96.10M | 98.60M | |||
| Other Current Assets | 37.22M | 21.93M | 21.50M | 15.20M | 14.80M | |||
| Total Current Assets | 745.61M | 745.13M | 509.99M | 498.30M | 866.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 201.71M | 216.39M | 234.95M | 254.40M | 264.80M | |||
| Investments And Advances | 18.81M | 35.65M | 38.46M | 64.40M | 22.00M | |||
| Goodwill | 20.30M | 0.00 | 163.24M | 163.20M | 145.20M | |||
| Intangibles | 422.56M | 425.97M | 483.26M | 540.50M | 624.00M | |||
| Other Non-Current Assets | 128.27M | 130.38M | 144.49M | 160.30M | 153.40M | |||
| Total Non-Current Assets | 791.65M | 808.39M | 1.06B | 1.18B | 1.21B | |||
| TOTAL ASSETS | 1.54B | 1.55B | 1.57B | 1.68B | 2.08B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 202.40M | 201.78M | 8.64M | 33.60M | 374.70M | |||
| Accrued Expenses | 80.64M | 78.40M | 64.52M | 91.60M | 126.50M | |||
| Accounts Payable | 30.12M | 19.13M | 15.70M | 15.20M | 10.50M | |||
| Other Current Liabilities | N/A | 10.61M | 8.53M | 7.30M | 9.40M | |||
| Total Current Liabilities | 313.16M | 309.92M | 97.38M | 147.80M | 521.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 378.10M | 383.55M | 513.80M | 655.80M | 674.50M | |||
| Deferred Taxes/Income | 4.58M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 83.65M | 81.70M | 93.08M | 102.60M | 149.30M | |||
| Total Non-Current Liabilities | 466.33M | 465.25M | 606.87M | 758.40M | 823.80M | |||
| TOTAL LIABILITIES | 779.50M | 775.17M | 704.26M | 906.20M | 1.34B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -206.39M | -206.36M | -106.80M | -148.80M | -211.90M | |||
| Additional Paid In Capital | 1.04B | 1.01B | 976.63M | 924.10M | 942.10M | |||
| Common Shares | 48.00K | 47.00K | 46.00K | 0.00 | 0.00 | |||
| Treasury Stock | -75.52M | -25.12M | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 4.00M | 153.00K | 123.00K | 100.00K | 0.00 | |||
| Shares Outstanding | 44.90M | 46.24M | 46.48M | 45.90M | 44.70M | |||
| Tangible Book Value per Share | 7.01 | 7.62 | 4.81 | 1.55 | -0.87 | |||
| Total Shareholders' Equity | 757.77M | 778.35M | 870.13M | 775.00M | 730.40M | |||
| TOTAL LIABILITIES AND EQUITY | 1.54B | 1.55B | 1.57B | 1.68B | 2.08B | |||
| Statistics | ||||||||
| Debt/Equity | 0.50 | 0.49 | 0.59 | 0.85 | 0.92 | |||
| Current Ratio | 2.38 | 2.40 | 5.24 | 3.37 | 1.66 | |||
| Return On Assets (ROA) | -8.29% | -6.41% | 2.66% | 0.95% | 2.02% | |||
| Return On Equity (ROE) | -16.82% | -12.79% | 4.82% | 2.05% | 5.75% | |||
| Return On Invested Capital (ROIC) | 3.88% | 5.34% | 4.02% | 3.14% | 5.81% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 6.11% | 8.74% | 4.95% | 3.87% | 10.06% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 14.17% | 19.92% | 10.76% | 8.91% | 70.16% | |||
All data in USD , ROIC based on taxRate of 0.32